A clinical trial to study the effect of local injections on resolution of warts
Not Applicable
- Conditions
- Health Condition 1: null- Veeucae (Viral Warts)
- Registration Number
- CTRI/2017/06/008868
- Lead Sponsor
- Dr Aayush Gupta
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 120
Inclusion Criteria
Males or females more than 13 years of age presenting with multiple non genital warts.
The diagnosis of warts confirmed clinically
Exclusion Criteria
Age <13 years
History of prior allergic response to mumps, BCG or Candida antigen.
Pregnancy
Lactation
HIV infection
Iatrogenic immunosuppression
Primary immunosuppression
Acute febrile illness
Subjects who received any other treatments for their warts in the last month before enrolment
Past history of asthma or allergic skin disorders
Past history of meningitis or convulsions
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Clinical resolution of mother and distant wart in response to intralesional immunotherapy.Timepoint: 6 months after first injection
- Secondary Outcome Measures
Name Time Method Appearance of side effects due to intralesional immunotherapy <br/ ><br>Timepoint: 2, 4 , 6 ,8 and 12 weeks;Partial resolution of mother and distant wartsTimepoint: 2, 4, 6, 8 and 12 weeks